Mannitol is a completely harmless product that resembles sugar in taste and appearance. It is cheap and readily available, and licenses confirm the safety of mannitol.
For several years, scientists have studied laboratory rats and fruit flies. Recently, drug trials have moved to a new level – patients suffering from parkinsonism took part in the experiment. Among the volunteers were the former head of the Israeli Air Force, Avihu Bin-Nun, and Dan Nesseli, a retired Israeli army officer. Feedback from study participants who took mannitol positively assessed the changes in their well-being.
Eyewitness accounts
Avihu Bin-Nun claims that before the onset of the disease he did not use any medicine at all, even aspirin. With the development of Parkinson’s disease, he had to streamline the intake of a large number of drugs, laying them out in boxes. Moreover, some of the drugs had a high cost. After using mannitol, 1 tsp. a day for a month, he felt a significant improvement. Firstly, it is not necessary to increase the dosage of drugs, on the contrary, it can be reduced. Secondly, the weak and hoarse earlier voice got stronger.
Dani Wessely, a former athlete and healthy lifestyle advocate, in 2013 did not at first attach importance to the fact that his hand began to tremble a little. An examination by a neurologist, after a series of tests, showed that he was developing Parkinson’s disease. After treatment with mannitol, Dani Wessely recovered facial expressions, which turned into a mask with the development of the disease. He can already speak loudly, although until recently he was not able to do this.
An Israeli businessman who became a participant in the experiment after an exacerbation of Parkinson’s disease took mannitol for six months. He says that until recently, due to severe pain, he could only climb stairs on all fours. “After taking mannitol, the pain in the legs stopped, calm sleep returned, and the lost ability to smell, the activity of the mimic muscles of the face was restored,” the businessman claims.
Scientists’ comments
The results of the study are commented by Professor of the University of Tel Aviv Dani Segal, researcher at the Department of Molecular Microbiology and Biotechnology. “The research of the laboratory was aimed at the study of atypically folding proteins. The result of such chemical transformations was the formation of toxins. Getting into the human brain, they provoked the development of Parkinson’s disease and Alzheimer’s disease,” says Professor D. Segal.
Mannitol has become the most effective substance in slowing down the formation of alpha-synuclein protein clots. It was this protein that led to Parkinson’s disease. Israeli scientists at the initial stage of the study analyzed the properties of dozens of proteins, and found several effective substances to minimize the toxic effect, among which the championship was given to mannitol.
Studies of its properties were carried out in parallel on experimental animals in the laboratories of the universities of Tel Aviv and California (San Diego). Professor Dani Segal states: “After the administration of mannitol to laboratory mice, a decrease in alpha-synuclein protein clots was noted in their brains. In the control group of experimental animals, this effect was not observed.
Testimonials from more than 800 patients suffering from parkinsonism indicate that mannitol has reduced the intensity of symptoms. The name of the product comes from the biblical concept of “manna from heaven”. According to legend, manna had exceptional sweetness. Mannitol does not require a doctor’s prescription to purchase.
Source: https://www.facebook.com/TopIchilovClinic/